Serum Free Triiodothyronine and the Responsiveness to Clopidogrel in Patients Undergoing Elective Percutaneous Coronary Intervention

被引：1
|
作者：
Yicong Ye
Xiliang Zhao
Yong Zeng
机构：
[1] Capital Medical University,Department of Cardiology, Beijing Anzhen Hospital
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Clopidogrel; Thromboelastography; Low responders; Free triiodothyronine; Thyroid function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3077 / 3088
页数：11
相关论文
共 50 条
  • [1] Serum Free Triiodothyronine and the Responsiveness to Clopidogrel in Patients Undergoing Elective Percutaneous Coronary Intervention
    Ye, Yicong
    Zhao, Xiliang
    Zeng, Yong
    ADVANCES IN THERAPY, 2021, 38 (06) : 3077 - 3088
  • [2] Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention
    Lin, Gen-Min
    Li, Yi-Hwei
    Chu, Kai-Min
    Han, Chih-Lu
    HEART, 2011, 97 (13) : 1111 - 1111
  • [3] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [4] Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention
    Zhao, Xiliang
    Wang, Jin
    Li, Quan
    Ye, Yicong
    Zeng, Yong
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (03) : 487 - 496
  • [5] Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention
    Xiliang Zhao
    Jin Wang
    Quan Li
    Yicong Ye
    Yong Zeng
    Cardiovascular Drugs and Therapy, 2023, 37 : 487 - 496
  • [6] Resistance to antiplatelet drugs (aspirin, clopidogrel) in patients undergoing elective percutaneous coronary intervention
    Sulimov, V. A.
    Moroz, E. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 23 - 30
  • [7] Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Yang, Zhi Qiang
    Ma, Xiao Teng
    Shao, Qiao Yu
    Li, Qiu Xuan
    Wang, Yu Fei
    Liang, Jing
    Shen, Hua
    Li Liu, Xiao
    Shi, Dong Mei
    Zhou, Yu Jie
    Fang, Zhe
    Wang, Zhi Jian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (07)
  • [8] Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention
    Kim, Jang-Young
    Lee, Kyounghoon
    Shin, Myungsang
    Ahn, Minsoo
    Choe, Hyunmin
    Yoo, Byung-Su
    Yoon, Junghan
    Choe, Kyung-Hoon
    Lee, Seung-Hwan
    CIRCULATION JOURNAL, 2007, 71 (12) : 1867 - 1872
  • [9] Clopidogrel Before Elective Percutaneous Coronary Intervention
    Motovska, Zuzana
    Widimsky, Petr
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04): : 373 - 379
  • [10] Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
    Mahdieh, Nejat
    Rabbani, Ahmad
    Firouzi, Ata
    Zahedmehr, Ali
    Hoseinimoghaddam, Maryam
    Saedi, Sedigheh
    Sanati, Hamidreza
    Basiri, Hosseinali
    Noohi, Feridoun
    Rabbani, Bahareh
    Maleki, Majid
    CARDIOVASCULAR TOXICOLOGY, 2018, 18 (05) : 482 - 491
12345